Stage III Hepatocellular Cancer (CNLC Staging)
1 clinical trials · Condition
◉ Watch Stage III Hepatocellular Cancer (CNLC Staging)
| Record | Firm | Date |
|---|---|---|
| mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC (NCT05412589) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2022-06-10 |
Track Stage III Hepatocellular Cancer (CNLC Staging) automatically
Every clearance here is in the API, with alerts when new ones post.